Uveal Melanoma Market, By Diagnosis (Ultrasonography, Indocyanine green angiography, High resolution ultrasound Bio microscopy and Others), By Therapy (Radiation therapy, Surgical resection techniques, Transpupillary thermotherapy and Others), By End-User (Hospital, Ambulatory surgical centres, Ophthalmology clinics and Others), and By Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Trends, Analysis, and Forecast till 2034

Uveal Melanoma Market is expected to reach US$ 2.5 billion by 2034, growing at a CAGR of 5.9% from its estimated US$ 1.5 billion in 2024.

The iris, ciliary body, and choroid, which are situated behind the cornea and sclera, make up the three sections of the uvea. Uveal melanoma, also known as skin cancer, involves the iris choroid and cilira body. This is the stage at which the melanocytes that give the eye its color start to grow tumors inside the uva. It is the most common type of intraocular malignancy in adults, despite being a rare disorder. The most crucial factor in deciding how to treat uveal melanoma is the tumor's size. This In its early stages, this type of melanoma is essentially asymptomatic. Tumor enlargement with time can cause changes such as secondary retinal detachment and pupil distortion, which result in reduced visibility due to hazy vision. This kind of cancer is linked to light-colored or green eyes, fair hair, and advanced age. It is unknown what role inherited genetic abnormalities play in uveal melanoma.